Vera Bradley Announces Reporting Date for Fiscal Year 2017 Third Quarter Results
Nov 01, 2016 13:00 pm UTC| Business
FORT WAYNE, Ind., Nov. 01, 2016 -- Vera Bradley, Inc. (Nasdaq:VRA) (“Vera Bradley” or the “Company”) today announced that it plans to report results for the third quarter ended October 29, 2016 at 8:00 a.m. Eastern Time...
Coherus BioSciences Management to Present at Two Investor Healthcare Conferences in November
Nov 01, 2016 13:00 pm UTC| Business
REDWOOD CITY, Calif., Nov. 01, 2016 -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that senior management will present at two upcoming investor healthcare conferences in November. Management participation...
Nov 01, 2016 13:00 pm UTC| Business
NORTH ANDOVER, Mass., Nov. 01, 2016 -- JENSEN Tools + Supply (formerly known as Stanley Supply Services), the industry’s leading provider of product and services for electronics manufacture, assembly, diagnosis and...
MKS Instruments to Present at the Robert W. Baird & Co. 2016 Global Industrial Conference
Nov 01, 2016 13:00 pm UTC| Business
ANDOVER, Mass., Nov. 01, 2016 -- MKS Instruments, Inc. (NASDAQ:MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that Gerald G. Colella, Chief Executive...
Square 1 Bank Expands Equity Funds Group
Nov 01, 2016 13:00 pm UTC| Business
SAN FRANCISCO and BOSTON, Nov. 01, 2016 -- Square 1 Bank, a division of Pacific Western Bank, today announced that it has expanded its Equity Funds Group with the addition of two senior hires, Judy Lee and Chuck...
Navios Maritime Holdings Inc. Extends Exchange Offer & Waives Condition
Nov 01, 2016 12:56 pm UTC| Business
MONACO, Nov. 01, 2016 -- Navios Maritime Holdings Inc. (“Navios Holdings” or the “Company”) today announced that, in connection with its previously launched exchange offer and consent solicitation (the “Exchange Offer”)...
Chembio’s DPP® Zika Test Approved by Brazil’s Health Regulatory Agency
Nov 01, 2016 12:50 pm UTC| Business
MEDFORD, N.Y., Nov. 01, 2016 -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has received approval for commercial use of its...